The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allied Minds Ends Co-CEO Structure Amid Board Changes, Cost Cutting

Wed, 11th Dec 2019 09:39

(Alliance News) - Allied Minds PLC said Wednesday that Mike Turner is stepping down as co-chief executive officer in March next year, as part of a larger restructuring of the intellectual property commercialisation firm.

Turner will step down on March 10, when Joe Pignato will continue on as sole CEO.

Turner will stay with Allied Minds but focus on the company's restructuring. He will step down from the board.

Pignato said: "Working closely together as co-CEOs, Mike and I have achieved significant progress since the new, focused strategy was launched earlier this year and we have generated substantial value for shareholders during that period. We will soon complete this transitional phase, having transformed and right-sized the business, and are therefore reshaping the management team to further optimise our cost base."

Pignato also has agreed to reduce his annual bonus to 100% of his base salary from 150%. He is now the last employee remaining on the company's since-ended long-term incentive plan. Pignato also has agreed to forfeit his share awards from 2017 and 2018.

Allied Minds said Non-Executive Director Fritz Foley will be stepping down from the board, as well, to be replaced by Mark Lerdal, with immediate effect.

Activist investor Crystal Amber Fund Ltd had been angling for Lerdal's appointment. It owns a 17% stake in Allied Minds.

Lerdal is currently executive chair at Leaf Clean Energy Co.

Crystal Amber has previously decried the leadership of Allied Minds, believing they have not been acting in the best interests of shareholders.

The investor has blamed "excessive" headquarter costs and misaligned incentive arrangements, as well as the fact that Allied Minds has not returned any cash to shareholders since 2014.

As well as seeking the removal of Foley and Turner, Crystal Amber has sought to remove Non-Executive Chair Jeffrey Rohr, who Allied Minds said Wednesday will retire at end of his second three-year term in June 2020.

Due to the changes announced Wednesday, Crystal Amber has agreed to withdraw its notice of requisition.

As part of the restructuring, Allied Minds was hoping to shave a further USD7.5 million off its recurring HQ expenses, but updated that guidance on Wednesday saying the figure will now be "no more" than USD6.0 million.

The cost reduction will begin in 2020, the company said.

On a positive note, however, Allied Minds said it will now return USD40 million to shareholders from the sale of its stake in radio frequency data analytics firm HawkEye 360 - up from the original USD32.8 million planned. The company said the rise was due to increased cost savings.

The shareholder return will be completed by the first quarter of 2020.

Pignato added: "The measures announced today will allow the business to maintain the necessary investment in key areas, in order to further support our portfolio companies on their path towards meaningful commercialisation, ensuring that the company remains on track to deliver attractive returns to all our shareholders in the coming years."

Shares in Allied Minds were 0.8% higher in London on Wednesday at 45.40 pence each.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2016 08:30

Allied Minds raises £5m from Neil Woodford for prostate cancer technology

(ShareCast News) - Star UK fund manager Neil Woodford has bought £5m of new shares in Allied Minds subsidiary Precision Biopsy. Woodford Investment Management, which is already a substantial shareholder in FTSE 250-listed Allied Minds purchased 0.95m preference shares in Precision Biopsy. Having de

Read more
29 Sep 2016 08:12

Allied Minds partners with GE Ventures to commercialise emerging tech

(ShareCast News) - FTSE 250 intellectual property company Allied Minds partnered with General Electric's venture capital subsidiary to commercialise next generation technologies. Allied Minds and GE Ventures agreed to invest in new and existing technologies from each of their innovation pipelines.

Read more
25 Aug 2016 08:05

Allied Minds losses increase but focus remains on future potential

(ShareCast News) - Allied Minds, the university and government technology commercialisation specialist, reported an increased loss, smaller revenue and flat value of its investment assets over the first half of the year. However, the company remains more firmly focused on investing in its various as

Read more
22 Aug 2016 07:07

Allied Minds secures debt funding and raises funds for drug programme

(ShareCast News) - Venture capital-style investor Allied Minds has arranged a one-year debt facility Silicon Valley Bank in the US, while its drug discovery subsidiary has raised funds for its leading project from institutional investors. Secured over certain group assets, the $20m one-year facility

Read more
1 Aug 2016 08:12

Allied Minds investment SciFluor gets nod from FDA

(ShareCast News) - Life science and technology investor Allied Minds announced on Monday that one of its key subsidiaries, SciFluor Life Sciences, has achieved the necessary scientific and regulatory milestones to enter clinical trials. The FTSE 250 company said SciFluor's Investigational New Drug a

Read more
13 Jun 2016 16:35

DIRECTOR DEALINGS: Allied Minds COO Marc Eichenberger Sells Shares

Read more
27 May 2016 15:30

FTSE 250 movers: Phoenix Group firms on AXA Wealth deal

(ShareCast News) - FTSE 250 was marginally firmer in late afternoon trade as UK traders wound down ahead of a long weekend, with few of today's in-the-news mid-cap stocks figuring among that index's top-10 risers. Shares in Phoenix Group Holdings were ahead as it agreed with AXA UK to buy AXA Wealth

Read more
25 May 2016 10:04

Allied Minds announces successful completion of feasibility programme

(ShareCast News) - Allied Minds' partnership with Bristol-Myers Squibb (BMS), Allied-Bristol Life Sciences, has successfully completed the drug candidate feasibility programme ABLS II and has approved up to $15m to fund further development of the lead optimisation programme. ABLS II is seeking to de

Read more
25 May 2016 07:08

Allied Minds Approves USD15 Million Funding For Allied-Bristol

Read more
19 May 2016 15:03

AGM, EGM Calendar - Week Ahead

Read more
13 May 2016 11:42

DIRECTOR DEALINGS: Allied Minds COO Sells 49,242 Shares

Read more
26 Apr 2016 09:30

WINNERS & LOSERS SUMMARY: Cobham Crushed On Weak Profit, Rights Issue

Read more
26 Apr 2016 08:47

Allied Minds secures £55m funding for up to ten new drugs

(ShareCast News) - Science and technology development and commercialisation company Allied Minds announced a fresh $80m (£55m) of investment commitments on Tuesday, received through its newly-formed subsidiary ABLS Capital. The FTSE 250 firm said the funding would allow up to ten potential lead opti

Read more
26 Apr 2016 06:50

Allied Minds Secures USD80 Million Commitments For Drug Development

Read more
25 Apr 2016 14:07

FTSE 250 movers: Ted Baker boosted as strike threat hits Wood Group

(ShareCast News) - The FTSE 250 remained in the black in afternoon trading on Monday, though some stocks were under the pump as crude and copper prices fell. Ted Baker was one of the leading risers, after analysts at Jefferies upgraded the stock to 'buy' from 'hold', though they did cut the price ta

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.